The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)

The Lancet

Volumn 390, Issue 10112, 2017, Pages 2569-2582

  Bhakta, Nickhill ^a   Liu, Qi ^b   Ness, Kirsten K ^a   Baassiri, Malek ^a   Eissa, Hesham ^a   Yeo, Frederick ^a   Chemaitilly, Wassim ^a,c   Ehrhardt, Matthew J ^a   Bass, Johnnie ^a   Bishop, Michael W ^a   Shelton, Kyla ^a   Lu, Lu ^a   Huang, Sujuan ^a   Li, Zhenghong ^a   Caron, Eric ^a   Lanctot, Jennifer ^a   Howell, Carrie ^a   Folse, Timothy ^a   Joshi, Vijaya ^c   Green, Daniel M ^a   Mulrooney, Daniel A ^a   Armstrong, Gregory T ^a   Krull, Kevin R ^a   Brinkman, Tara M ^a   Khan, Raja B ^a   Srivastava, Deo K ^a   Hudson, Melissa M ^a   Yasui, Yutaka ^a   Robison, Leslie L ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANTHRACYCLINE; ANTINEOPLASTIC METAL COMPLEX; BLEOMYCIN; CYTARABINE; METHOTREXATE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CANCER THERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CHILDHOOD CANCER SURVIVOR; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE BURDEN; FEMALE; FOLLOW UP; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; ICD-10; ICD-9; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINOBLASTOMA; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; AGE; COMPLICATION; COST OF ILLNESS; MIDDLE AGED; MORTALITY; NEOPLASM; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CANCER SURVIVORS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 85028862270     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31610-0     Document Type: Article

References (30)

1. Armstrong, GT, Chen, Y, Yasui, Y, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 374 (2016), 833–842.
2. Howlader, N, Noone, AM, Krapcho, M, et al. SEER Cancer Statistics Review (CSR), 1975–2014. https://seer.cancer.gov/csr/1975_2014/, June 28, 2017 (accessed Aug 1, 2017).
3. Winther, JF, Kenborg, L, Byrne, J, et al. Childhood cancer survivor cohorts in Europe. Acta Oncol 54 (2015), 655–668.
4. Fidler, MM, Reulen, RC, Winter, DL, et al., On behalf of the British Childhood Cancer Survivor Study Steering Group. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ, 354, 2016, i4351.
5. Robison, LL, Hudson, MM, Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 14 (2014), 61–70.
6. Oeffinger, KC, Mertens, AC, Sklar, CA, et al., for the Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 (2006), 1572–1582.
7. Hudson, MM, Ness, KK, Gurney, JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309 (2013), 2371–2381.
8. Geenen, MM, Cardous-Ubbink, MC, Kremer, LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297 (2007), 2705–2715.
9. Bhatia, S, Armenian, SH, Armstrong, GT, et al. Collaborative research in childhood cancer survivorship: the current landscape. J Clin Oncol 33 (2015), 3055–3064.
10. Reulen, RC, Frobisher, C, Winter, DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305 (2011), 2311–2319.
11. Hudson, MM, Ness, KK, Nolan, VG, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer 56 (2011), 825–836.
12. Bhakta, N, Liu, Q, Yeo, F, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 17 (2016), 1325–1334.
13. Landier, W, Bhatia, S, Eshelman, DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22 (2004), 4979–4990.
14. Hudson, MM, Ehrhardt, MJ, Bhakta, N, et al. Approach for classification and severity-grading of long-term and late-onset health events among childhood cancer survivors in the St. Jude lifetime cohort. Cancer Epidemiol Biomarkers Prev 26 (2017), 666–674.
15. Kelly, TL, Wilson, KE, Heymsfield, SB, Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One, 4, 2009, e7038.
16. Molenberghs, G, Fitzmaurice, GM, Kenward, MG, Tsiatis, AA, Verbeke, G, Handbook of missing data methodology, 2015, CRC Press, Taylor & Francis Group, Boca Raton, 233–266.
17. Little, RJ, Rubin, DB, Statistical analysis with missing data, 2nd edn., 2014, Wiley, New York, 200–222.
18. Dong, H, Robison, LL, Leisenring, WM, Martin, LJ, Armstrong, GT, Yasui, Y, Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count. Am J Epidemiol 181 (2015), 532–540.
19. Geskus, RB, Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics 67 (2011), 39–49.
20. Berridge, DM, An application of a marked point process in pre-clinical medicine. Stat Med 15 (1996), 2751–2762.
21. Rebholz, CE, Reulen, RC, Toogood, AA, et al. Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 29 (2011), 4181–4188.
22. Aznar, MC, Darby, S, Collins, GP, Cutter, D, Cumulative burden of disease: a relevant measure of the late side-effects of cancer treatment. Lancet Oncol 17 (2016), 1189–1190.
23. Hudson, MM, Neglia, JP, Woods, WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer 58 (2012), 334–343.
24. Oeffinger, KC, McCabe, MS, Models for delivering survivorship care. J Clin Oncol 24 (2006), 5117–5124.
25. Suh, E, Daugherty, CK, Wroblewski, K, et al. General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med 160 (2014), 11–17.
26. Sieswerda, E, Font-Gonzalez, A, Reitsma, JB, et al. High hospitalization rates in survivors of childhood cancer: a longitudinal follow-up study using medical record linkage. PLoS One, 11, 2016, e0159518.
27. Brewster, DH, Clark, D, Hopkins, L, et al. Subsequent hospitalisation experience of 5-year survivors of childhood, adolescent, and young adult cancer in Scotland: a population based, retrospective cohort study. Br J Cancer 110 (2014), 1342–1350.
28. Pappas, G, Yujiang, J, Seiler, N, et al. Perspectives on the role of patient-centered medical homes in HIV Care. Am J Public Health 104 (2014), e49–e53.
29. Dale, SB, Ghosh, A, Peikes, DN, et al. Two-year costs and quality in the comprehensive primary care initiative. N Engl J Med 374 (2016), 2345–2356.
30. Krull, KR, Cheung, YT, Liu, W, et al. Chemotherapy pharmacodynamics and neuroimaging and neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 34 (2016), 2644–2653.